BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monge P, Søgaard AB, Andersen DG, Chandrawati R, Zelikin AN. Synthetic chemical ligands and cognate antibodies for biorthogonal drug targeting and cell engineering. Adv Drug Deliv Rev 2021;170:281-93. [PMID: 33486005 DOI: 10.1016/j.addr.2021.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang M, Chattopadhyay AN, Rotello VM. Cell-Based Chemical Safety Assessment and Therapeutic Discovery Using Array-Based Sensors. IJMS 2022;23:3672. [DOI: 10.3390/ijms23073672] [Reference Citation Analysis]
2 Ebrahimnejad P, Sodagar Taleghani A, Asare-Addo K, Nokhodchi A. An updated review of folate-functionalized nanocarriers: A promising ligand in cancer. Drug Discov Today 2021:S1359-6446(21)00490-6. [PMID: 34781032 DOI: 10.1016/j.drudis.2021.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Gormley AJ, Spicer CD, Chandrawati R. Self-assembly and bioconjugation in drug delivery. Adv Drug Deliv Rev 2021;174:628-9. [PMID: 34022270 DOI: 10.1016/j.addr.2021.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Monge P, Løvschall KB, Søgaard AB, Walther R, Golbek TW, Schmüser L, Weidner T, Zelikin AN. Synthetic Artificial Apoptosis‐Inducing Receptor for On‐Demand Deactivation of Engineered Cells. Advanced Science 2021;8:2004432. [DOI: 10.1002/advs.202004432] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]